Therapeutic removal of amyloid deposits by anti amyloid antibodies

被引：0
|
作者：
Clos, A. [3 ]
Lasagna-Reeves, C. [1 ]
Wagner, R. [2 ]
Pettit, M. [2 ]
Kelly, B. [2 ]
Wilkerson, M. [2 ]
Jackson, G. [1 ]
Kayed, R. [1 ]
机构：
[1] Univ Texas Galveston, Med Branch, Dept Neurol, Galveston, TX 77550 USA
[2] Univ Texas Galveston, Med Branch, Dept Dermatol, Galveston, TX 77550 USA
[3] Univ Texas Galveston, Med Branch, Sch Med, Galveston, TX 77550 USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2010年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
113
引用
收藏
页码：S19 / S19
页数：1
相关论文
共 50 条
  • [1] Therapeutic removal of amyloid deposits in cutaneous amyloidosis by localised intra-lesional injections of anti-amyloid antibodies
    Clos, Audra L.
    Lasagna-Reeves, Cristian A.
    Wagner, Richard
    Kelly, Brent
    Jackson, George R.
    Kayed, Rakez
    EXPERIMENTAL DERMATOLOGY, 2010, 19 (10) : 904 - 911
  • [2] Monoclonal antibodies and amyloid removal as a therapeutic strategy for cardiac amyloidosis
    Emdin, Michele
    Morfino, Paolo
    Crosta, Lucia
    Aimo, Alberto
    Vergaro, Giuseppe
    Castiglione, Vincenzo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25 (SUPPB) : B79 - B84
  • [3] Therapeutic anti-amyloid β antibodies cause neuronal disturbances
    Adhikari, Utpal Kumar
    Khan, Rizwan
    Mikhael, Meena
    Balez, Rachelle
    David, Monique Antoinette
    Mahns, David
    Hardy, John
    Tayebi, Mourad
    ALZHEIMERS & DEMENTIA, 2022, : 2479 - 2496
  • [4] Anti-amyloid antibodies
    Gross, M
    CHEMISTRY IN BRITAIN, 2002, 38 (04) : 20 - 20
  • [5] Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component
    Richards, Duncan B.
    Cookson, Louise M.
    Berges, Alienor C.
    Barton, Sharon V.
    Lane, Thirusha
    Ritter, James M.
    Fontana, Marianna
    Moon, James C.
    Pinzani, Massimo
    Gillmore, Julian D.
    Hawkins, Philip N.
    Pepys, Mark B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (12): : 1106 - 1114
  • [6] Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
    Karl Bodin
    Stephan Ellmerich
    Melvyn C. Kahan
    Glenys A. Tennent
    Andrzej Loesch
    Janet A. Gilbertson
    Winston L. Hutchinson
    Palma P. Mangione
    J. Ruth Gallimore
    David J. Millar
    Shane Minogue
    Amar P. Dhillon
    Graham W. Taylor
    Arthur R. Bradwell
    Aviva Petrie
    Julian D. Gillmore
    Vittorio Bellotti
    Marina Botto
    Philip N. Hawkins
    Mark B. Pepys
    Nature, 2010, 468 : 93 - 97
  • [7] Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
    Bodin, Karl
    Ellmerich, Stephan
    Kahan, Melvyn C.
    Tennent, Glenys A.
    Loesch, Andrzej
    Gilbertson, Janet A.
    Hutchinson, Winston L.
    Mangione, Palma P.
    Gallimore, J. Ruth
    Millar, David J.
    Minogue, Shane
    Dhillon, Amar P.
    Taylor, Graham W.
    Bradwell, Arthur R.
    Petrie, Aviva
    Gillmore, Julian D.
    Bellotti, Vittorio
    Botto, Marina
    Hawkins, Philip N.
    Pepys, Mark B.
    NATURE, 2010, 468 (7320) : 93 - 97
  • [8] Immunotherapeutic clearance of systemic amyloid deposits by antibodies to serum amyloid P component
    Pepys, Mark B.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2017, 24 : 5 - 6
  • [9] New therapeutic perspectives – amyloid removal
    Mark Pepys
    Orphanet Journal of Rare Diseases, 10 (Suppl 1)
  • [10] Design and Optimization of Anti-amyloid Domain Antibodies Specific for β-Amyloid and Islet Amyloid Polypeptide
    Lee, Christine C.
    Julian, Mark C.
    Tiller, Kathryn E.
    Meng, Fanling
    DuConge, Sarah E.
    Akter, Rehana
    Raleigh, Daniel P.
    Tessier, Peter M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (06) : 2858 - 2873
12345